CleanCore Prices a Cash Reset Before Settlement

Conditional Short Watchlist | ZONE | U.S. common stock | Research only

CleanCore Solutions priced a best-efforts public offering of common stock, pre-funded warrants, and investor warrants on August 11. The headline is approximately $100 million of gross proceeds. The filing evidence does not yet provide a post-closing cash and share-count bridge.

That distinction matters. The offering proposes 275.8 million common shares, 124.2 million pre-funded warrants with a nominal exercise price, and 400 million investor warrants exercisable at $0.25. Against the latest filed 221.9 million common shares, the immediate common-equivalent claim is already about 1.8 times the stale denominator before the out-of-the-money warrant layer is considered. The $0.25 financing price is a reference point, not a floor.

The selected opportunity is a conditional short bias, not an executable trade. The company can invalidate it with a clean settlement, durable cash, no resale, and evidence that its AI infrastructure pivot produces financing or operating cash. Live locate, borrow, liquidity, and positioning data are unverified.

Opportunity Ranking

This run screened four fresh U.S.-listed candidates using SEC filing searches built around unusual combinations of best-efforts offering settlement, pre-funded warrant denominator, AI infrastructure cash requirement, ELOC access cap, production funding gap, and clinical resale registration. Recently covered HYLN, SCWO, CHAI, BTDR, VELO, and VATE mechanisms were excluded from selection to avoid republishing the same financing thesis.

Rank	Candidate	Fresh evidence and market snapshot	Why it could move more than 5%	Decision
1	ZONE, CleanCore Solutions	August 11 424B5 and August 12 8-K price a $100M gross offering with 800M total common-equivalent claim capacity. Latest provider reference: $0.145, -8.17%, 38.7M volume, August 12 21:20 UTC.	Settlement, actual share issuance, a first resale, or a post-close cash surprise can change the denominator and the market's interpretation quickly.	Selected
2	SEV, Aptera Motors	August 12 10-Q and 8-K show $10.1M quarter-end cash, $15.9M six-month operating cash use, and an estimated $40M to $45M needed for initial low-volume production. Latest reference: $2.24, +2.28%, August 12 21:35 UTC.	Production orders and a funding announcement can squeeze; a financing or delivery miss can reset the equity.	Rejected: more operating optionality and a less immediate share-claim catalyst.
3	ONCO, Onconetix	August 12 S-1 seeks to register up to 100M resale shares, but the filing says only 789,426 common shares could initially be issued under the Nasdaq exchange cap without shareholder approval. Cash was approximately $5.4M as of August 10. Latest reference: $0.8916, -6.04%, August 12 21:35 UTC.	Registration effectiveness, ELOC access, shareholder approval, or a cash bridge can move a very small equity quickly.	Rejected: most headline supply is approval- and registration-dependent.
4	CAMP, CAMP4 Therapeutics	August 12 424B3 registers resale of 10.8M common shares and 21.9M pre-funded-warrant shares from an older private placement. Latest reference: $4.53, +8.87%, August 12 21:58:59 UTC.	A clinical catalyst can overwhelm resale arithmetic, while an actual resale can expose the denominator.	Rejected: stronger clinical squeeze risk and less urgent financing-state change.

Scope Audit

The user scope for this run was U.S. market short opportunities only. The research therefore ranked U.S.-listed equities and did not treat non-U.S. lanes as finalists.

Why This Is the Best Opportunity Right Now

ZONE has the clearest disagreement between a financing headline and what is actually known about the post-financing company:

Evidence freshness: the pricing 8-K is dated August 12, and the 424B5 is dated August 11. The latest 10-Q is still for the period ended March 31.
Denominator tension: the offering combines common stock, nearly dollar-for-dollar pre-funded warrants, and a large warrant layer against a 221.9M filed common denominator.
Catalyst urgency: the prospectus expected delivery on or about August 12, subject to customary closing conditions. The next closing, share-count, or cash filing should separate priced capacity from settled capital.
Surprise potential: the gross offering is more than three times the provider's approximately $31.3M market-cap field, but that field is not reconciled to a post-offering denominator.
Tradeability discipline: the price has already fallen, but the available data does not establish borrowable supply or a clean short. The best opportunity is therefore a filing-gated Watchlist, not a market order.

Why This Can Jump or Dump More Than 5% Soon

Direction: the near-term fundamental pressure is downward if settlement, actual issuance, or resale confirms a larger common-equivalent claim without a commensurate operating cash bridge. The near-term squeeze direction is upward if the offering settles cleanly, investors retain the securities, the warrants remain out of the money, or the AI pivot receives strategic funding.

Trigger: the first post-closing cash and share-count reconciliation, a resale or exercise filing, a revised cash disclosure, or a binding AI infrastructure funding announcement.

Timeframe: days to six weeks for financing-state filings and the first tape reaction; longer for the next full operating filing.

Evidence quality: high for the offering structure, medium for the price reference, and low for live positioning because locate, borrow, short-interest, options, dealer-flow, fund-flow, spread, depth, venue, and exit-liquidity data are not verified.

What Should Surprise a Sophisticated Reader

The surprising point is not that CleanCore has financing capacity. It is that the market can read a priced offering as a cash reset even while the filing chain still leaves four separate states unresolved:

the offering was priced, but post-close cash receipt is not yet reconciled;
common and pre-funded securities were offered, but the post-close issued denominator is not yet shown;
investor warrants are immediately exercisable at $0.25, but the latest reference is $0.145, so they are not current in-the-money supply;
90-day lock-up and issuance restrictions can delay supply, but they do not remove the claim stack.

The latest 10-Q also carries a data-quality warning. The 424B5 says previously filed March 31 unaudited statements should no longer be relied upon and should be restated because of an unrecorded 70 million Dogecoin transfer. That makes a neat current enterprise-value calculation less reliable than a state-by-state financing bridge.

The Setup

On August 11, CleanCore priced a best-efforts offering of 275,829,576 common shares, 124,170,424 pre-funded warrants, and 400,000,000 investor warrants. Common stock with an accompanying investor warrant was priced at $0.25. A pre-funded warrant with an accompanying investor warrant was priced at $0.2499. The pre-funded warrants are exercisable at $0.0001 and do not expire until exercised in full. The investor warrants are exercisable immediately at $0.25 and expire on the fifth anniversary of the initial exercise date.

The 8-K describes approximately $100.0M of aggregate gross proceeds before placement-agent fees and offering expenses. The 424B5 shows an 8% cash fee, or approximately $8.0M on the stated gross amount, and $92.0M of proceeds before other expenses. Those are offering calculations, not a confirmed post-closing bank balance.

The prospectus says expected delivery was on or about August 12, subject to customary closing conditions. The current SEC filing set reviewed for this note does not yet show the post-close cash, issued common shares, pre-funded exercises, investor-warrant exercises, or actual holder resales.

The operating context is also transitional rather than self-funding:

CleanCore says it sold substantially all of its remaining 463 million Dogecoin on July 20 for approximately $33.4M and is using the treasury transition to fund an AI Critical Infrastructure business.
The latest March 31 10-Q showed $4.1M of cash and cash equivalents, $13.0M of restricted cash, and $49.2M of digital assets. Its cash-flow statement reported $17.1M of cash at period-end, so cash classification and availability require reconciliation.
Nine-month operating cash use was $14.8M, while net cash used in investing was $130.3M, largely reflecting digital-asset purchases. Net loss was $148.5M, with a substantial non-cash digital-asset fair-value component.
The prospectus describes an initial Minnesota data-center project of approximately 40 megawatts and says the company expects to fund the first 200 megawatts of a broader plan with $100M by the first quarter of 2027. This is a capital requirement and project plan, not current AI revenue.

The Market Price

The latest market snapshot available for this run is a provider reference, not an executable regular-session entry.

Field	Observation	Source and timestamp
Latest reference price	$0.145	Finance-provider snapshot, August 12, 2026 21:20 UTC
Change	-$0.0129, -8.17%	Same snapshot
Intraday range	$0.130 to $0.160	Same snapshot
Intraday volume	38,732,711 shares	Same snapshot
Provider market capitalization	$31.3M	Same snapshot; not reconciled post-offering
Financing reference	$0.25	CleanCore 424B5, August 11, 2026

At $0.145, the stock is 42% below the $0.25 financing reference. That gap can mean a failed financing signal, a post-pricing supply response, a temporary mismatch between reference and settlement, or a squeeze setup if the deal settles and holders do not sell. It does not tell us which one is true.

The Financing and Claim Bridge

State	Filed quantity or term	What it supports	What it does not prove
Common shares offered	275.829576M	Potential immediate common denominator increase after settlement	Actual shares issued, held, or resold
Pre-funded warrants	124.170424M at $0.0001 exercise	Near-common-equivalent claim capacity	Immediate float or exercise before a filing
Investor warrants	400.000M at $0.25 exercise	A large future claim and a squeeze-sensitive overhang	Current in-the-money supply at $0.145
Total common-equivalent capacity in the package	800.000M before beneficial-ownership limits	Stress case versus the latest filed 221.939M common shares	A current denominator or current borrowable float
Latest filed common shares	221.938856M as of May 8	The latest denominator available before this offering	The post-offering denominator
Stated gross proceeds	Approximately $100M	The scale of the priced transaction	Cash already received and unrestricted
Placement and capital-markets fee	8%	At least $8M of stated gross proceeds is contractually allocated before other expenses	Net cash available after all costs
Lock-up and issuance restrictions	90 days, with a 180-day variable-transaction restriction	A possible delay to some new supply	Elimination of the offering claim or proof of holder retention

The immediate common-equivalent portion of the package, 275.8M common shares plus 124.2M pre-funded warrants, is about 1.80 times the latest filed common denominator. Including the 400M investor-warrant layer produces a theoretical 800M shares, about 3.61 times that stale denominator. These are scenario bounds, not issued shares.

The Positioning

Observed: ZONE fell 8.17% on reported volume of 38.7M shares. That volume is roughly 17% of the stale May common denominator. The move establishes a repricing event and a possible financing reaction.

Unknown: volume does not identify short sales, holder resale, pre-funded exercise, or dealer positioning. I do not have verified same-session short interest, locate quality, borrow fee, recall terms, options open interest and skew, dealer flow, fund flow, venue-level depth, or exit liquidity.

Positioning is therefore capped at 3/5. A large theoretical supply stack is not executable short supply.

The Catalyst Path

Closing and settlement disclosure: Test whether the best-efforts offering closed, how much cash was actually received, what fees and expenses were paid, and how many common shares and pre-funded warrants were issued or exercised.
Post-close denominator: Reconcile the new common count to the provider market-cap field. Do not add the 400M investor warrants to current float unless exercise is documented.
First resale or exercise: Look for a filing showing actual holder sales, pre-funded exercise, investor-warrant exercise, or resale registration activity. Registration and contractual eligibility are not evidence of selling.
Next cash and operating filing: Bridge unrestricted cash, restricted cash, digital assets, operating burn, debt and other claims after the Dogecoin sale and the offering.
AI project funding: Test whether the Minnesota project has binding counterparties, funding, power, construction, customer commitments, revenue, or cash collection. A project plan is not an operating bridge.

The cheapest disconfirming sequence is the first closing or settlement filing, the next share-count and cash disclosure, the first documented resale or exercise, and the first filed AI-funding or operating-cash bridge. If the company receives durable net cash, avoids common-equivalent resale, and secures non-dilutive or operating funding, the short thesis should be downgraded quickly.

The Gap

The market may be pricing the $100M headline as if CleanCore has already received cash and completed a strategic reset. The filings support a narrower conclusion:

the offering was priced at a significant premium to the latest reference price, but closing and net cash are not yet reconciled;
the common and pre-funded package can be large relative to the stale common denominator, but the issued count and actual resale are unknown;
the warrants are immediately exercisable but out of the money at the latest reference price;
the company has a real Dogecoin-sale and AI-infrastructure narrative, but the current business has not yet supplied a clean operating cash bridge;
the latest balance-sheet evidence is stale, and the prospectus flags a prior restatement issue.

The short thesis is therefore a settlement, denominator, and cash-conversion disagreement, not a claim that CleanCore cannot build an AI infrastructure business. A correct operating story can still produce a squeeze if the financing is clean. A financing headline can still fail if the post-close denominator and cash bridge do not support it.

Price Target and Probability Map

These are analytical scenarios, not broker targets, guaranteed exits, or personalized financial advice. For a short, the Top Case is the favorable downside case and the Bottom Case is the adverse squeeze case. Gross short return is calculated from the $0.145 reference price and excludes borrow, fees, slippage, taxes, halts, financing costs, and gap risk.

Scenario	Probability	Target / Level	Return / Payoff	Time Horizon	Conditions Required	Evidence Quality
Top Case for the short	30%	$0.070	+51.7% gross short return	2 to 6 weeks	Settlement or resale confirms supply, cash remains weak or opaque, and the AI funding bridge fails to arrive	Medium
Base Case	45%	$0.105	+27.6% gross short return	2 to 8 weeks	The offering settles but cash conversion, denominator clarity, and project funding remain unresolved	Medium
Bottom Case for the short	25%	$0.250	-72.4% gross short return	Days to 4 weeks	Net cash is confirmed, holders retain securities, the 90-day restriction matters, and strategic or AI funding creates a squeeze	Low to Medium
Invalidation / Stop Condition	n/a	Filed cash and share-count bridge supports the reset, or price accepts above $0.25 with confirming fundamentals	Review or exit, not a target	At every filing and regular session	A clean cash reset, no resale, and credible project funding defeat the short; no numeric stop is responsible before an entry exists	High for filing evidence

Probability-weighted expected value: the price-only weighted target is approximately $0.131, implying approximately +9.8% gross short return from $0.145 before all costs. Executable expected value is unknown because locate, borrow, spread, depth, venue, exit liquidity, and squeeze conditions are unverified.

Current market price / level: $0.145 provider reference.

Timestamp: August 12, 2026 21:20 UTC; latest available provider snapshot, after regular trading hours.

Primary instrument: ZONE common stock, NYSE American.

Alternative expressions considered: no options or leverage. A put or put spread would require a verified live chain, open interest, spread, implied volatility, borrow-equivalent economics, and exit liquidity, none of which were verified.

Confidence: Medium on the financing-state disagreement; Low to Medium on the price map; Low on execution.

What Could Go Wrong

The strongest counterparty argument is that the financing is real and the market is underpricing a newly capitalized AI infrastructure company. If the offering closes, the company receives substantial net cash, investors hold rather than resell, the warrants stay out of the money, and the Minnesota project secures a customer or strategic funding, the current price can be too low. The $0.25 price paid by investors would then function as evidence of institutional willingness to fund the transition, not as a failed financing.

Other risks are concrete:

The offering can close and deliver more usable cash than the stale March 31 balance sheet implies.
The 90-day lock-up and 180-day variable-transaction restriction can delay expected supply.
House of Doge participation and strategic relationships can provide funding or market support that is not visible in the current operating numbers.
The Dogecoin sale can fund the AI pivot faster than the short assumes.
A very low-priced, high-volume stock can halt, gap, or squeeze before a filing clarifies the structure.
The investor warrants are out of the money at $0.145, but a move toward $0.25 can make the warrant layer a future supply source rather than an immediate burden.
The current market-cap field is close to the stale filed denominator but cannot validate any post-offering enterprise value.
The prior accounting restatement warning means the historical balance sheet should not be treated as a precise current asset floor.

What Would Prove This Wrong

Retire or materially downgrade the short thesis if the next disclosures show all or most of the following:

The offering closed and produced verified net cash after fees and expenses.
The post-close common and pre-funded share count is materially below the full stress case, with no documented resale pressure.
Cash remains unrestricted and adequate after operating burn, project commitments, and other claims.
The Minnesota project or another AI infrastructure opportunity has binding funding, power, customer, construction, and revenue evidence.
The stock holds above $0.25 on verified regular-session liquidity while the cash and operating bridge confirms the reset.

A price below $0.07 would not prove the thesis if it resulted from a halt, a thin venue, or temporary technical dislocation. A price above $0.25 would be a risk review, not automatic fundamental invalidation, unless it is paired with the filed cash and project evidence above.

Best Trade Strategy

Direction: Conditional short bias, research only.

Preferred instrument: ZONE common stock only after every execution gate passes. No options expression is recommended because the live chain and liquidity were not verified.

Common-stock stance: Watchlist. entry.price = null; execution.can_execute = false.

Entry trigger: Require a verified locate and borrow with acceptable fee and recall terms; a fresh regular-session quote that is not the $0.130 intraday low; acceptable NBBO spread, order-book depth, venue quality, volume quality, and exit liquidity; and a filed settlement, share-count, cash, resale, or failed-continuation catalyst. Stage any later exposure over multiple sessions. Do not short the first print after a halt or chase a thin-volume breakdown.

Take-profit map: Analytical base target $0.105 and extension target $0.070. These are scenario levels, not guaranteed exits.

Stop and invalidation: No numeric stop is responsible while entry is null. If all gates later pass, precommit a loss limit above the $0.25 financing reference with a gap plan, and exit or reassess on a filed cash-and-denominator bridge that supports the reset. The financing reference is not a hard floor.

Timeline: Settlement and share-count evidence can arrive immediately; the next cash and operating filing is the main adjudicator over the following weeks. The exact next earnings date was not verified.

Execution risks: no verified locate or borrow, recall risk, wide spread, shallow depth, venue fragmentation, halt risk, stale market-cap data, after-hours reference pricing, potential investor retention, and a high-volatility squeeze into the $0.25 warrant price.

Do not trade if: borrow is unavailable or recall terms are unacceptable; the only quote is delayed, post-market, or near an intraday low; the offering is not settled; spread or depth is poor; a market order or leverage is required; exit liquidity is unverified; or a new filing shows durable net cash and project funding.

Monitoring checklist:

Closing status, net cash, fees, expenses, common shares delivered, pre-funded exercises, and investor-warrant exercises.
Post-close share count versus the 221.939M May 8 denominator and the $31.3M provider market-cap field.
First actual holder resale, registration, exercise, or transfer filing.
Unrestricted cash, restricted cash, Dogecoin-sale proceeds, digital assets, operating cash use, debt, commitments, and restatement updates.
Minnesota project power, construction, funding, counterparties, customer commitments, revenue, and cash collection.
Same-session locate, borrow fee, recall terms, short interest, options, dealer flow, fund flow, spread, depth, venue quality, volume quality, and exit liquidity.

Bottom Line

CleanCore is the best fresh U.S. short candidate from this run because the market can price a $100M gross offering as a cash reset before the filing chain proves settlement, net cash, the new denominator, or actual resale. The package contains 400M common and pre-funded shares plus 400M warrants against a stale 221.9M common base, but that is a claim-stack stress case, not current float.

The proper posture is a conditional Short Watchlist with a price-only map, no options or leverage, entry.price set to null, execution.can_execute = false, and a filing-gated test of whether the AI transition becomes a funded operating business.

Canonical Rubric and Research Quality Scorecard

Criterion	Score	Reason
Market disagreement	5/5	A priced $100M gross offering is being interpreted against an unresolved settlement, denominator, and cash bridge
Evidence base	5/5	Fresh SEC 8-K and 424B5 are paired with the latest 10-Q and timestamped market snapshot
Positioning and flows	3/5	Price and volume are observed, but live short, borrow, options, dealer, fund, spread, depth, and exit data are missing
Catalyst path	5/5	Closing, cash, share count, first resale, and AI-funding disclosures form a concrete adjudication sequence
Payoff architecture	4/5	Explicit 100%-sum scenarios and price-only expected return, but executable value is unknown
Invalidation discipline	5/5	Net cash, denominator, no-resale, project-funding, and price-acceptance invalidators are explicit
Differentiated insight	4/5	The key separation is priced capacity versus settled cash, issued claims, and actual resale
Client value	4/5	The filing sequence is useful even if no borrow appears, though the current execution state is blocked
Total	35/40	Conditional Short Watchlist

Section 17 quality gate: yes for a specific mispricing, primary evidence, explicit positioning gap, catalyst path, downside case, counterparty argument, 100%-sum scenarios, dedicated scorecard, Markdown tables, Best Trade Strategy, sourced price, and inline illustration prompt. No unsupported live execution claim is made.

Sources

Source	Tier	Used for
CleanCore August 12, 2026 Form 8-K	Primary SEC filing	Offering price, securities, stated gross proceeds, best-efforts structure, fees, warrants, and lock-up terms
CleanCore August 11, 2026 Form 424B5	Primary SEC filing	Share and warrant quantities, $0.25 pricing, pre-funded exercise, expected delivery, Dogecoin sale, AI project plan, historical balance-sheet warning, and fee schedule
CleanCore March 31, 2026 Form 10-Q	Primary SEC filing	Latest filed common denominator, cash, restricted cash, digital assets, operating cash use, investing cash use, net loss, and going-concern language
ZONE Yahoo Finance quote	Market data	Latest provider reference price, move, range, volume, and market-cap snapshot at August 12, 2026 21:20 UTC
Aptera August 12, 2026 Form 10-Q	Primary SEC filing	Ranked alternative's cash and operating-cash-use bridge
Aptera August 12, 2026 Form 8-K	Primary SEC filing	Ranked alternative's production funding requirement and financing update
Onconetix August 12, 2026 Form S-1	Primary SEC filing	Ranked alternative's resale registration, Nasdaq exchange cap, ELOC structure, and cash disclosure
CAMP4 August 12, 2026 Form 424B3	Primary SEC filing	Ranked alternative's resale and pre-funded-warrant structure

AI Illustration Prompt

Create a restrained, high-end institutional editorial illustration for The Mispricing Desk about CleanCore Solutions (ZONE): a microcap company that prices a $100 million gross financing while the post-settlement cash and share denominator remain unresolved. Build the image as a split ledger on warm paper. On the left, a deep navy financing panel labelled "Priced Aug 11", "$100M gross", "275.8M common", "124.2M pre-funded", and "400M warrants at $0.25". On the right, a muted amber unresolved panel labelled "Cash received?", "Shares issued?", "Resales?", "AI project funding", and "next filing". Put a thin bridge between the panels with four stamped states: "priced", "settled", "issued", "resold". Add a restrained red price tag reading "ZONE $0.145, -8.17%" and a small separate marker reading "$0.25 financing reference, not a floor". Include a faint Dogecoin coin silhouette transitioning into a clean data-center outline, without making crypto the focal point. Use paper white, graphite, deep navy, steel blue, muted amber, and one controlled red execution accent. The mood is analytical, sober, institutional, and unresolved. Avoid rockets, memes, casino imagery, generic candlestick charts, cartoon money, people in focus, and promotional AI clichés. Add a subtle semi-transparent "The Mispricing Desk" watermark in the lower-right corner. Render as realistic, high-value, high-end elite, beautiful master image.